DE69907193D1 - Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen - Google Patents

Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Info

Publication number
DE69907193D1
DE69907193D1 DE69907193T DE69907193T DE69907193D1 DE 69907193 D1 DE69907193 D1 DE 69907193D1 DE 69907193 T DE69907193 T DE 69907193T DE 69907193 T DE69907193 T DE 69907193T DE 69907193 D1 DE69907193 D1 DE 69907193D1
Authority
DE
Germany
Prior art keywords
vitamin
vulvitis
esters
muscine
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69907193T
Other languages
English (en)
Other versions
DE69907193T2 (de
Inventor
Giorgio Panin
Eleonora Annunziata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69907193(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69907193D1 publication Critical patent/DE69907193D1/de
Publication of DE69907193T2 publication Critical patent/DE69907193T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69907193T 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen Expired - Lifetime DE69907193T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI981586 1998-07-10
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (2)

Publication Number Publication Date
DE69907193D1 true DE69907193D1 (de) 2003-05-28
DE69907193T2 DE69907193T2 (de) 2004-04-08

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907193T Expired - Lifetime DE69907193T2 (de) 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Country Status (22)

Country Link
EP (1) EP1094807B1 (de)
JP (1) JP2002520281A (de)
CN (1) CN1135975C (de)
AT (1) ATE238051T1 (de)
AU (1) AU762860B2 (de)
BR (1) BR9911945A (de)
CA (1) CA2336990A1 (de)
CZ (1) CZ301019B6 (de)
DE (1) DE69907193T2 (de)
DK (1) DK1094807T3 (de)
ES (1) ES2196813T3 (de)
HU (1) HU228921B1 (de)
IL (1) IL140759A0 (de)
IT (1) ITMI981586A1 (de)
NO (1) NO20006719L (de)
NZ (1) NZ509129A (de)
PL (1) PL345500A1 (de)
PT (1) PT1094807E (de)
RU (2) RU2221561C2 (de)
SK (1) SK284464B6 (de)
TR (2) TR200100014T2 (de)
WO (1) WO2000002554A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CN107468648A (zh) * 2008-10-09 2017-12-15 拉姆斯科股份有限公司 治疗干眼综合征的组合物和方法
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
EP2459186B1 (de) * 2009-07-27 2013-10-09 Salvatore Troisi Ophthalmische lösung zur schützung von internen strukturen des auges gegen uv-a strahlen oder zur behandlung von keratoconus mit trans-epithelialer cross-linking technik
KR102162901B1 (ko) 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
US10251861B2 (en) * 2012-06-08 2019-04-09 Ohio State Innovation Foundation Methods for treating burn and scar injury using tocotrienol compositions
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
PL3209294T3 (pl) 2014-10-22 2020-01-31 Bio.Lo.Ga. S.R.L. Kompozycja farmaceutyczna do stosowania w zwiększaniu trofizmu błony śluzowej nosa
ES2856553T3 (es) * 2015-03-18 2021-09-27 Bionoox Suisse Sa Composiciones que comprenden dihidroquercetina para uso en métodos para el tratamiento del herpes
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
CN115666523A (zh) 2020-03-26 2023-01-31 Plx 奥普科有限公司 能够进行pH依赖性重构的药物载体及其制备和使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
ITMI981586A0 (it) 1998-07-10
NO20006719D0 (no) 2000-12-29
CN1135975C (zh) 2004-01-28
NZ509129A (en) 2003-10-31
CN1308531A (zh) 2001-08-15
CA2336990A1 (en) 2000-01-20
DE69907193T2 (de) 2004-04-08
HUP0102781A2 (hu) 2001-12-28
HU228921B1 (en) 2013-06-28
JP2002520281A (ja) 2002-07-09
RU2221561C2 (ru) 2004-01-20
CZ200136A3 (cs) 2001-08-15
BR9911945A (pt) 2001-03-27
AU4385899A (en) 2000-02-01
EP1094807A1 (de) 2001-05-02
CZ301019B6 (cs) 2009-10-14
ATE238051T1 (de) 2003-05-15
ES2196813T3 (es) 2003-12-16
PL345500A1 (en) 2001-12-17
RU2003128023A (ru) 2005-04-10
AU762860B2 (en) 2003-07-10
DK1094807T3 (da) 2003-08-11
IL140759A0 (en) 2002-02-10
EP1094807B1 (de) 2003-04-23
SK352001A3 (en) 2001-06-11
HUP0102781A3 (en) 2002-04-29
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
ITMI981586A1 (it) 2000-01-10
TR200100014T2 (tr) 2001-06-21
TR200103710T2 (tr) 2002-06-21
NO20006719L (no) 2001-02-16
PT1094807E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
DE69907193D1 (de) Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen
NO20044699L (no) Vaginalpleiesammensetning
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
ATE337785T1 (de) Tiotropiumsalze zur behandlung von entzündlichen erkrankungen
ME01310B (me) Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa-1-gama aktivatori u lečenju dijabetesa
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
ATE215366T1 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
NO20061214L (no) 2,4-pyrimidindiaminer nyttige i behandling av neoplastiske sykdomme,r inflammatoriske forstyrrelser og immunsystemforstyrrelser
EA200400881A1 (ru) Азаарилпиперазины
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
ES2182915T3 (es) Procedimiento de purificacion del factor viii
NO20032271D0 (no) GABA-enhancere i behandlingen av sykdommer relatert til redusert nevrosteroidaktivitet
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
DK1128835T3 (da) Cyanocobalamin (vitamin 12)-behandling ved allergisk sygdom
ATE350011T1 (de) Pharmazeutische zusammensetzung zur behandlung von ulzerationen und/oder erosionen des schleimhautepithels
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
ATE345123T1 (de) Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE602004016542D1 (de) Medikament auf basis von honig, seine herstellung und verwendung
ATE270098T1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
ATE307805T1 (de) Imidazolonderivate zur behandlung viraler krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition